Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_assertion description "[Glibenclamide (glyburide) treatment was started at 23 months and resulted in insulin being discontinued, lower overall glycaemia, reduced glucose fluctuations and reduced hypoglycaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_assertion evidence source_evidence_literature NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_assertion SIO_000772 17047922 NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_assertion wasDerivedFrom befree-2016 NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_assertion wasGeneratedBy ECO_0000203 NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP574968.RAIPT-D4G5CkioW34cbGSkZJoQepcoLSDKzcp1oD_9HyQ130_provenance.